Qiagen NV | QIA - Operating Profit

Stock Price
43.48
Daily Change
0.003 0.01%
Monthly
2.63%
Yearly
9.64%
Q1 Forecast
43.53

Qiagen NV reported $137.29M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Alaunos Therapeutics USD -1.19M 432K Sep/2025
argenx SE USD 349.97M 146.13M Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -260M 647M Sep/2025
Organon & Co USD 388M 62M Sep/2025
Qiagen NV USD 137.29M 1.32M Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025